(Q37847073)

24 August 2017

1 reference

title

Molecular targeted therapy for hepatocellular carcinoma in the current and potential next strategies (English)

1 reference

24 August 2017

main subject

hepatocellular carcinoma

1 reference

1

Shinji Tanaka

1 reference

24 August 2017

Shigeki Arii

2

1 reference

24 August 2017

language of work or name

1 reference

25 February 2011

1 reference

Journal of Gastroenterology

24 August 2017

published in

1 reference

24 August 2017

volume

46

1 reference

24 August 2017

issue

3

1 reference

24 August 2017

page(s)

289-296

1 reference

Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. The Liver Cancer Study Group of Japan

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Cancer. Addiction to oncogenes--the Achilles heal of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Molecularly targeted therapy for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Molecular targeted therapies in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Cancer stem cells and chemoradiation resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Current status and perspective of antiangiogenic therapy for cancer: hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

VEGF and the quest for tumour angiogenesis factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Role of platelet-derived growth factors in physiology and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Soluble receptor-mediated selective inhibition of VEGFR and PDGFRbeta signaling during physiologic and tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Altered expression of vascular endothelial growth factor, fibroblast growth factor-2 and endostatin in patients with hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Sorafenib in advanced hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Safety and efficacy of sunitinib in patients with advanced hepatocellular carcinoma: an open-label, multicentre, phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Induction of angiopoietin-2 gene expression by COX-2: a novel role for COX-2 inhibitors during hepatocarcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Oncogenic signal transduction and therapeutic strategy for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Hepatocellular carcinoma pathogenesis: from genes to environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Aurora-kinase inhibitors as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

The selective Aurora B kinase inhibitor AZD1152 as a novel treatment for hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Hypoxia-inducible factors, stem cells, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Oxygen in Stem Cell Biology: A Critical Component of the Stem Cell Niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Maintenance of quiescent hematopoietic stem cells in the osteoblastic niche.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Cancer stem cells and their niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

A perivascular niche for brain tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Aurora-a is essential for the tumorigenic capacity and chemoresistance of colorectal cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

CD13 is a therapeutic target in human liver cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

A novel frizzled gene identified in human esophageal carcinoma mediates APC/beta-catenin signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Functional consequences of frizzled-7 receptor overexpression in human hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Human WISP1v, a member of the CCN family, is associated with invasive cholangiocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

The concept of synthetic lethality in the context of anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Synthetic lethality--a new direction in cancer-drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00535-011-0387-9

Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma

21 January 2018

1 reference

12 December 2020

Clinical significance of vascular endothelial growth factor and basic fibroblast growth factor gene expression in liver tumor

1 reference

12 December 2020

Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy

1 reference

12 December 2020

Genetics of natural populations; recombination and variability in populations of Drosophila pseudoobscura.

1 reference

12 December 2020

Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases

1 reference

12 December 2020

Gene expression signature of the gross morphology in hepatocellular carcinoma

1 reference

12 December 2020

O2 regulates stem cells through Wnt/β-catenin signalling.

1 reference

12 December 2020

Regorafenib (BAY 73-4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity

1 reference

12 December 2020

10.1007/S00535-011-0387-9

Identifiers

DOI

1 reference

24 August 2017

1 reference